Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Hari Gorla

  • Home
  • Author: Hari Gorla

Hungary unlikely to meet its Zrínyi 2026 spending target due to economic impact of COVID-19, says GlobalData

Hungary’s defense budget saw an increase over the 2017-2021 period due to the announcement of its modernization program, Zrínyi 2026. The government will develop its defense fleet through several important procurements and increase its defense expenditure to reach 2% of its overall GDP by 2024. However, Hungary is unlikely to meet its Zrínyi 2026 spending […]
Read more

Venture capital investors continue to bet big on low value deals in Asia-Pacific during Q2 2021, finds GlobalData

Low value deals (≤ US$10m) accounted for most of the venture capital (VC) investment volume in the Asia-Pacific (APAC) region while billion-dollar deals remained mostly non-existent during the second quarter (Q2) of 2021, according to GlobalData, a leading data and analytics company. An analysis of GlobalData’s Financial Deals Database reveals that the region saw the […]
Read more

Automakers collaborate to lead all-inclusive electrification in Japan, says GlobalData

With Japan eyeing to achieve carbon-neutrality by 2050, key automakers in the country now have the impetus to begin their transition towards electric vehicles (EVs). Given the governmental targets and increasing intrusion of technology giants in EV manufacturing and supply, Japanese OEMs have been quite active recently in partnering/collaborating with various stakeholders for developing EVs, […]
Read more

Sales of anti-neoplastic agents for non-proliferative diabetic retinopathy will triple within two years, says GlobalData

There are more than nine pharmaceutical companies developing therapeutics that can be used to treat non-proliferative diabetic retinopathy (NPDR) in the nine major markets (9MM*), says GlobalData. According to the leading data and analytics company, sales of drugs launching between 2021 and 2028 for NPDR are expected to reach $1.8bn. According to GlobalData’s report, ‘Diabetic […]
Read more

Boston Scientific’s neuromodulation segment will need to perform strongly in Q3 to recoup 2020 losses

Following the recent release of Boston Scientific’s Q2 financial information; Dominic Tong, Senior Medical Device Analyst at GlobalData, a leading data and analytics company, offers his view: “Boston Scientific reported a Q2 2021 growth of 101.5% in its neuromodulation segment to a revenue of $247m compared to Q2 2020’s revenue of $122m, though this figure […]
Read more

Europcar acquisition could be a smart move for Volkswagen, says GlobalData

Following confirmation that French car rental group Europcar’s owners are in advanced discussions with a consortium including Volkswagen that is interested in a possible takeover; David Leggett, Automotive Analyst at GlobalData, a leading data and analytics company, offers his view: “Debt-laden Europcar could be relatively cheap as the car rental sector reels under the impact […]
Read more

Myanmar political crisis, international sanctions to shrink 2021 construction output by 7.7%, forecasts GlobalData

Myanmar’s construction industry output in 2020 was affected by the COVID-19 pandemic induced supply chain disruptions and labor shortages. In 2021, the industry’s weakness is expected to be further compounded by the ongoing political crisis and its impact on foreign investments and construction progress, with the industry output projected to contract by 7.7% in real […]
Read more

Sullivan & Cromwell and Kirkland & Ellis were top M&A legal advisers by value and volume in construction sector for H1 2021, finds GlobalData

Sullivan & Cromwell and Kirkland & Ellis were the top mergers and acquisitions (M&A) legal advisers in the construction sector for H1 2021 by value and volume, respectively. Sullivan & Cromwell advised on seven deals worth $41.7bn, which was the highest value among all advisers tracked. Meanwhile, Kirkland & Ellis led in terms of volume, […]
Read more

Private equity firms are acquiring top CMOs at a rapid rate, says GlobalData

Acquisitions of pharmaceutical contract manufacturing organizations (CMOs) are increasing, and the most common type of acquirer is private equity (PE) firms, which view the industry as a prudent choice for a return on investment, according to GlobalData, a leading data and analytics company. The company’s report, ‘M&A in the Contract Manufacturing Industry: Implications and Outlook […]
Read more

Cleary Gottlieb Steen & Hamilton and Watson Farley & Williams were top M&A legal advisers by value and volume in power sector for H1 2021, finds GlobalData

Cleary Gottlieb Steen & Hamilton and Watson Farley & Williams were the top mergers and acquisitions (M&A) legal advisers in the power sector for H1 2021 by value and volume, respectively. According to the deals database by leading data and analytics company GlobalData, Cleary Gottlieb Steen & Hamilton advised on seven deals worth $25.3bn, which […]
Read more
1 … 23 24 25 26 27 … 60